{
    "nct_id": "NCT00356148",
    "official_title": "Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.\n\nExclusion Criteria:\n\n* Ductal carcinoma in situ (DCIS; stage 0 cancer),\n* Advanced or distant metastatic stage,\n* Receiving any neoadjuvant therapy,\n* History of receiving any antibiotics within prior 3 months,\n* History of immunodeficiency,\n* Having a remote infection,\n* History of reaction to study antibiotics,\n* Denial of signing the consent form.\n\nsex: FEMALE\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.",
        "exclusion": "Ductal carcinoma in situ (DCIS; stage 0 cancer), Advanced or distant metastatic stage, Receiving any neoadjuvant therapy, History of receiving any antibiotics within prior 3 months, History of immunodeficiency, Having a remote infection, History of reaction to study antibiotics, Denial of signing the consent form."
    }
}